
Migace 200mg Tablet SR
Marketer
Novalab Healthcare Pvt Ltd
Salt Composition
Aceclofenac (200mg)
Overview Migace 200mg Tablet SR
Rheumacin 200mg Extended-Release Tablets provide analgesic relief. This medication targets pain and inflammation associated with conditions such as rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis. Dosage and treatment duration for Rheumacin 200mg Extended-Release Tablets should strictly follow your physician's instructions. Administering the medication with food or milk minimizes potential stomach irritation. Consistent, timely intake enhances therapeutic efficacy. Continue using the medication as directed by your doctor; premature discontinuation is discouraged. Commonly reported adverse effects include nausea, vomiting, indigestion, and abdominal discomfort. Dizziness, somnolence, or blurred vision may also occur. Prolonged therapy may necessitate regular monitoring of renal and hepatic function, along with blood work. Extended use carries a risk of severe complications, including gastrointestinal bleeding and renal impairment. Rheumacin 200mg Extended-Release Tablets are contraindicated during pregnancy and lactation.
Uses of Migace 200mg Tablet SR
Analgesia
Major Benefits of Migace 200mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Migace 200mg Tablet SR whole; do not damage the tablet by chewing, crushing, or breaking it. Administer this medication with food.
Common Side effects of Migace 200mg Tablet SR:
- Vomiting
- Stomach pain/epigastric pain
- Nausea
- Indigestion
- Diarrhea
- Heartburn
- Loss of appetite
How to use Migace 200mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Migace 200mg Extended-Release Tablets should be administered with food.
How Migace 200mg Tablet SR works:
Migace 200mg sustained-release tablets are a non-steroidal anti-inflammatory drug (NSAID) that inhibits the production of inflammatory mediators responsible for pain and associated inflammation, such as redness and swelling.
SAFETY ADVICE
AlcoholUNSAFE
Combining Migace 200mg Tablet SR and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Extended-release Migace 200mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Migace 200mg sustained-release tablets while breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking Migace 200mg SR tablets might reduce alertness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Exercise caution when prescribing Migace 200mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician before administering. Migace 200mg SR tablets are contraindicated in patients exhibiting severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Migace 200mg SR tablets cautiously, potentially requiring dosage modification. Severe hepatic disease contraindicates Migace 200mg SR tablet use. Physician consultation is recommended. Routine liver function monitoring is advised during treatment.
What if you forget to take Migace 200mg Tablet SR :
Should you forget a Migace 200mg Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Migace 200mg Tablet SR
| Label | Value |
|---|---|
| Chemical Type | Dichlorobenzene Derivative |
| Developing Habits | No. |
| Type of Therapy | Pain Relievers |
| Behavior Class | Nonselective COX-1 and COX-2 inhibitors (acetic acid NSAIDs) |
